FDA 483 - Martha I. Buitrago, M.D. - April 01, 2016

Martha I. Buitrago, M.D. in Idaho Falls, ID was inspected as a clinical investigator, revealing significant deviations from a clinical study protocol. The firm failed to conduct an investigation in accordance with the investigational plan, including administering placebo instead of the study drug to subjects and not reporting these events to the institutional review board. Additionally, a subject did not complete an unscheduled visit or receive required sample collection and testing.